Last reviewed · How we verify
Exfoliative Erythroderma
Approved treatments
- Depo-Medrol · Pfizer
Depo-Medrol works by binding to the glucocorticoid receptor, which then regulates the expression of genes involved in inflammation and immune response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Exfoliative Erythroderma patent landscape — cliff calendar, originator estates, attackable patents
- Exfoliative Erythroderma treatment landscape brief
- Exfoliative Erythroderma treatment updates RSS
Frequently asked questions about Exfoliative Erythroderma
What drugs treat Exfoliative Erythroderma?
Tracked treatments include Depo-Medrol.
What is the treatment for Exfoliative Erythroderma?
Standard treatment for Exfoliative Erythroderma includes Depo-Medrol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Exfoliative Erythroderma patent cliff · Exfoliative Erythroderma CI report
- Treatment: Depo-Medrol · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing